1. Home
  2. GME vs JAZZ Comparison

GME vs JAZZ Comparison

Compare GME & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GameStop Corporation

GME

GameStop Corporation

HOLD

Current Price

$22.17

Market Cap

10.7B

ML Signal

HOLD

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$232.14

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GME
JAZZ
Founded
1996
2003
Country
United States
Ireland
Employees
N/A
N/A
Industry
Electronics Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
10.4B
IPO Year
2005
2007

Fundamental Metrics

Financial Performance
Metric
GME
JAZZ
Price
$22.17
$232.14
Analyst Decision
Sell
Strong Buy
Analyst Count
1
14
Target Price
$13.50
$217.57
AVG Volume (30 Days)
9.2M
873.1K
Earning Date
06-09-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
133.33
N/A
EPS
0.77
4.43
Revenue
$3,629,900,000.00
$1,618,693,000.00
Revenue This Year
$18.98
$6.22
Revenue Next Year
N/A
$7.68
P/E Ratio
$29.19
$51.50
Revenue Growth
N/A
N/A
52 Week Low
$19.94
$105.00
52 Week High
$35.81
$230.40

Technical Indicators

Market Signals
Indicator
GME
JAZZ
Relative Strength Index (RSI) 39.35 74.47
Support Level $20.43 $128.87
Resistance Level $23.10 N/A
Average True Range (ATR) 1.16 5.99
MACD -0.36 2.07
Stochastic Oscillator 3.47 92.17

Price Performance

Historical Comparison
GME
JAZZ

About GME GameStop Corporation

GameStop Corp offers games, collectibles, and entertainment products through its stores and ecommerce platforms. Its products include Hardware and accessories offering new and pre-owned gaming platforms from the console manufacturers, Software offering new and pre-owned gaming software for current and certain prior generation consoles and sell a wide range of in-game digital currency, digital downloadable content and full-game downloads, and Collectibles consist of apparel, toys, trading cards, gadgets and other retail products for pop culture and technology enthusiasts and collectibles related services, such as submission services for the authentication and grading of trading cards. The company operates its business in three geographic segments: the United States, Australia, and Europe.

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Share on Social Networks: